ApprovalTrail

Approval · Notice of Compliance 11533 · 2010

MELOXICAM: Notice of Compliance 11533

Issued June 18, 2010

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
11533
Date
June 18, 2010
Company
Sanis Health Inc.Brampton, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
New manufacturer and product name
Therapeutic class
Non-steroidal anti-inflammatory drug (NSAID)
Canadian reference product
MOBICOX (Boehringer Ingelheim (Canada) Ltd.)

Products in this notice

BrandDINStatus today
MELOXICAM02353148Marketed
MELOXICAM02353156Marketed

Medicinal ingredients